IDO1 and rheumatoid arthritis: Interestingly, a recent study on RA patients revealed that expression levels of CD83 and IDO1 were elevated in the blood of those patients who responded to therapy with abatacept (a fusion protein of CTLA-4 and IgG1, which affects DC biology and T cell stimulation) [93].